Evotec AG implements Contur Software’s Enterprise ELN system
Complete the form below to unlock access to ALL audio articles.
ConturELN covers Evotec’s global research activities across all drug discovery disciplines and has been integrated with Evotec’s existing cheminformatics platform.
“The ability of ConturELN to satisfy the detailed demands of our global Chemistry, Biology,
Pharmacology, Structural Biology and Analysis teams provides us with a significant advantage in helping us achieve effective and integrated data management, delivering benefits to our drug discovery partners”, says Dr. Steve Courtney, Senior Vice President Drug Discovery at Evotec AG.
“We are pleased that Evotec has chosen ConturELN as its ELN provider. Implementing an Enterprise ELN and satisfying the needs of all disciplines is a challenge which requires the right combination of software, methodology and people”, says Mr. Thomas Rozlucki, Director Marketing at Contur Software.